Showing results (101-110 of 202) with videos related to

Sort By:
Pageof 21
Plos One|December 11, 2012
Home videophones improve direct observation in tuberculosis treatment: a mixed methods evaluationVictoria A Wade, Jonathan Karnon, Jaklin A Eliott, et al.
International Journal of Cardiology|December 25, 2008
A cost-utility analysis of clopidogrel in patients with ST elevation acute coronary syndromes in the UKJonathan Karnon, Mike W Holmes, Robert Williams, et al.
Applied Ergonomics|November 29, 2016
The stage of change approach for implementing ergonomics advice - Translating research into practicePaul Rothmore, Paul Aylward, Jodi Oakman, et al.
Australian Health Review : a Publication of the Australian Hospital Association|July 6, 2019
Clinical indications treated with unregistered antimicrobials: regulatory challenges of antimicrobial resistance and access to effective treatment for patientsNadine T Hillock, Lisa Paradiso, John Turnidge, et al.
Pharmacoeconomics|December 24, 2017
Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health SystemLaura Catherine Edney, Hossein Haji Ali Afzali, Terence Chai Cheng, et al.
Applied Health Economics and Health Policy|June 17, 2025
Discrete Event Simulation in R using the 'Simmer' Package for Health Economic Modelling: A Tutorial and Illustration in Colon CancerKoen Degeling, Jonathan Karnon, Michiel van de Ven, et al.
Joint Commission Journal on Quality and Patient Safety|December 8, 2018
Reasons for Repeat Rapid Response Team Calls, and Associations with In-Hospital MortalityRichard Chalwin, Lynne Giles, Amy Salter, et al.
Jac-Antimicrobial Resistance|July 5, 2021
Feasibility of de-linking reimbursement of antimicrobials from sales: the Australian perspective as a qualitative case studyNadine T Hillock, Tracy L Merlin, Jonathan Karnon, et al.
Plos One|November 3, 2012
The cost of treating advanced non-small cell lung cancer: estimates from the chinese experienceXiaohui Zeng, Jonathan Karnon, Siying Wang, et al.
International Journal of Technology Assessment in Health Care|November 3, 2020
Value assessment of antimicrobials and the implications for development, access, and funding of effective treatments: Australian stakeholder perspectiveNadine T Hillock, Tracy L Merlin, Jonathan Karnon, et al.
Pageof 21